A Phase 1 interventional study of arginine hydrochloride in diabetic ketoacidosis
Recruiting Phase 1,Phase 2 NCT07167693
Study Description
Testing whether arginine amino acid infusion can help the body make more insulin during diabetic ketoacidosis in Type 2 diabetes
Study Details
- Registry ID:
- NCT07167693
- Conditions:
- Diabetes (DM), Diabetic Ketoacidosis, Ketosis Prone Diabetes, Hyperglycaemia (Diabetic)
- Phase:
- Phase 1,Phase 2
- Target Enrollment:
- 60 participants
- Start Date:
- Age Range:
- 18–999 years
- Healthy Volunteers:
- No
Study Locations (1 site)
-
Detroit Medical Center
Detroit, Michigan, United States
Interested in Participating?
Check your eligibility and learn more about this study on TrialScreen.